The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.
Nov 8, 2023
0
0
Americans have been getting COVID treatments such as Paxlovid for free, but that's about to end.
Oct 30, 2023
0
8
A new, more inclusive definition of infertility has been crafted by the American Society for Reproductive Medicine (ASRM).
Oct 25, 2023
0
0
Americans seeking out the new COVID boosters are finding themselves held back by insurance entanglements and supply delays.
Sep 22, 2023
0
14
Eighteen U.S. states have laws that allow insurance companies to deny health care payments to treat people who were intoxicated when they sustained an injury, despite evidence showing that these laws prevent people from receiving ...
Sep 19, 2023
0
1
For patients with chronic conditions, including inflammatory bowel disease (IBD), newer drugs like biologics can be very effective—but also very expensive.
Sep 11, 2023
0
0
With three-quarters of Americans obese or overweight, interest in weight-loss treatments is at an all-time high. Three injectable medications have dominated the spotlight of late: Wegovy, Ozempic and Mounjaro. These once-a-week, ...
Sep 8, 2023
0
1
Genetic tests can provide life-saving information. They can help diagnose disease, enable access to preventive care, prompt early screening and treatment, and guide patients' therapeutic options.
Sep 7, 2023
0
1
New research published in Cancer Epidemiology, Biomarkers & Prevention finds that engaging in administrative tasks to estimate costs or pay for care among a cohort of cancer patients and survivors was associated with an 18% ...
Aug 30, 2023
0
13
Sally Nix was furious when her health insurance company refused to pay for the infusions she needs to ease her chronic pain and fatigue.
Aug 29, 2023
0
1
